Michael Haller, MD, professor and chief, Pediatric Endocrinology, University of Florida.
Michael Haller, MD, discusses inhaled insulin and Afrezza data for type 1 diabetes
Manufacturer MannKind has submitted a supplemental Biologics Application to the FDA for its inhaled insulin Afrezza.